Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Other 1Gastrointestinal 1Breast 1

Conditions

Obesity 45Mucositis 29Neoplasms 23Sexual Dysfunction, Physiological 19Head and Neck Neoplasms 16Breast Neoplasms 16Opioid-Induced Constipation 12Dyspnea 11Constipation 11Pain 10Polycystic Ovary Syndrome 9Weight Loss 7Squamous Cell Carcinoma of Head and Neck 7Prostatic Neoplasms 7Motor Activity 7Diabetes Mellitus 7Cardiovascular Diseases 6Xerostomia 5Stomatitis 5Radiation Injuries 5Overweight 5Sedentary Behavior 4Endometrial Neoplasms 4Diabetes Mellitus, Type 2 4Colorectal Neoplasms 4Bronchiolitis Obliterans Syndrome 4Sexuality 3Salivary Gland Neoplasms 3Hypertension 3Fatty Liver 3

Interventions

Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Body Weight × Other × Clear all
NCT01537029 2018-08-22

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

Texas Tech University Health Sciences Center

Phase 4 Completed
15 enrolled 6 charts
BreastOther

Body Weight, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡